ARCHIVES

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

This article is from The Cancer Letter archive.

Vol. 17 No. 27 | July 5, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says

April 13, 1979

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003